Coronado Biosciences to Report Second Quarter 2013 Financial Results
July 25, 2013 08:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., July 25, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Announces Completion of Enrollment in TRUST-I Phase 2 Clinical Trial of TSO for Crohn's Disease
July 01, 2013 07:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., July 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Participate in Upcoming Healthcare Investor Conferences
June 21, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., June 21, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Appoints George Avgerinos, Ph.D. as Senior Vice President, Biologics Operations
June 04, 2013 16:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., June 4, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Present at the Jefferies 2013 Global Healthcare Conference
May 28, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 28, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Reports Financial Results for the First Quarter Ended March 31, 2013
May 08, 2013 07:18 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 8, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
May 07, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 06, 2013 07:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 6, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences to Report First Quarter 2013 Financial Results
May 01, 2013 08:00 ET
|
Coronado Biosciences
BURLINGTON, Mass., May 1, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...
Coronado Biosciences Announces Departure of Dr. Bobby W. Sandage, Jr.
April 24, 2013 08:30 ET
|
Coronado Biosciences
BURLINGTON, Mass., April 24, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the...